Given that ACE2 upregulation by bioactive peptides presents a new mechanism mediating the peptides’ beneficial health effects, our results further support the role of ACE2u peptides in ameliorating Ang II-induced pathological responses, which contributes to the treatment of hypertension. The gene discussed is ACE2; the disease is hypertensive disorder.